| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.2 | 0.0008 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |